NASDAQ Composite Index
23.365,69
PKT
+151,00
PKT
+0,65
%
Werbung
Analysen zu NASDAQ Composite Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.02.12 | Teva Pharmaceutical Industries buy | UBS AG | |
| 16.02.12 | Anglo American buy | Deutsche Bank AG | |
| 16.02.12 | Comcast buy | UBS AG | |
| 16.02.12 | Anglo American overweight | J.P. Morgan Cazenove | |
| 16.02.12 | Anglo American neutral | Nomura | |
| 16.02.12 | Baidu.com overweight | JP Morgan Chase & Co. | |
| 16.02.12 | Apple kaufen | Der Aktionär | |
| 16.02.12 | Baidu.com buy | Royal Bank of Scotland | |
| 15.02.12 | Salesforce buy | UBS AG | |
| 15.02.12 | Anglo American neutral | Citigroup Corp. | |
| 15.02.12 | Apple overweight | Barclays Capital | |
| 15.02.12 | Alphabet A (ex Google) overweight | Piper Jaffray & Co. | |
| 15.02.12 | Apple buy | Jefferies & Company Inc. | |
| 14.02.12 | Textron outperform | RBC Capital Markets | |
| 14.02.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 14.02.12 | Applied Materials neutral | UBS AG | |
| 14.02.12 | Baidu.com neutral | Credit Suisse Group | |
| 14.02.12 | Alphabet A (ex Google) overweight | Barclays Capital | |
| 14.02.12 | Baidu.com buy | Deutsche Bank Securities | |
| 13.02.12 | Biomarin Pharmaceutical outperform | RBC Capital Markets | |
| 13.02.12 | NuVasive neutral | Robert W. Baird & Co. Incorporated | |
| 13.02.12 | Microsoft buy | UBS AG | |
| 13.02.12 | Microsoft equal-weight | Barclays Capital | |
| 13.02.12 | Zions Bancorporation buy | D.A. Davidson & Co. | |
| 13.02.12 | Microsoft overweight | Barclays Capital | |
| 13.02.12 | Alexion Pharmaceuticals overweight | Barclays Capital | |
| 13.02.12 | Visa kaufen | Euro am Sonntag | |
| 13.02.12 | Expedia neutral | Nomura | |
| 13.02.12 | Expedia buy | Stifel, Nicolaus & Co., Inc. | |
| 10.02.12 | Alexion Pharmaceuticals outperform | Robert W. Baird & Co. Incorporated | |
| 10.02.12 | Amazon sector perform | Pacific Crest Securities Inc. | |
| 10.02.12 | Amazon outperform | RBC Capital Markets | |
| 10.02.12 | Visa outperform | RBC Capital Markets | |
| 10.02.12 | Akamai neutral | Credit Suisse Group | |
| 10.02.12 | Visa overweight | Barclays Capital | |
| 10.02.12 | Microchip Technology overweight | Barclays Capital | |
| 10.02.12 | Microsoft buy | Citigroup Corp. | |
| 10.02.12 | Visa outperform | Credit Suisse Group | |
| 10.02.12 | Akamai hold | Jefferies & Company Inc. | |
| 10.02.12 | Visa neutral | Citigroup Corp. |